Better Small-Cap Growth ETF: Vanguard’s VBK vs. State Street’s SLYG


  • VBK charges a lower expense ratio and holds a much larger asset base than SLYG.

  • VBK has delivered a higher 1-year total return but experienced a deeper five-year drawdown.

  • Sector tilts show both funds favor technology, but VBK leans even more heavily into this space.

  • These 10 stocks could mint the next wave of millionaires ›

The State Street SPDR S&P 600 Small Cap Growth ETF (NYSEMKT:SLYG) and the Vanguard Small-Cap Growth ETF (NYSEMKT:VBK) both target U.S. small-cap growth stocks, but VBK charges a lower fee, is far larger by assets under management, and shows a stronger recent performance record alongside higher volatility.

Both SLYG and VBK are designed to capture the upside of U.S. small-cap growth companies, though they track different benchmarks and use distinct selection criteria.

This comparison explores how their costs, returns, risk profiles, and portfolio tilts stack up for investors seeking exposure to fast-growing smaller firms.

Metric

SLYG

VBK

Issuer

SPDR

Vanguard

Expense ratio

0.15%

0.07%

1-yr return (as of Jan. 9, 2026)

10.2%

14.4%

Dividend yield

0.8%

0.5%

Beta

1.18

1.43

AUM

$3.7 billion

$39.7 billion

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months.

VBK looks more affordable, charging less than half the expense ratio of SLYG, though SLYG offers a slightly higher dividend yield over the past year.

Metric

SLYG

VBK

Max drawdown (5 y)

-29.18%

-38.39%

Growth of $1,000 over 5 years

$1,210

$1,145

VBK tracks a broad basket of 579 U.S. small-cap growth stocks, with technology (27%), industrials (21%), and healthcare (18%) as its largest sector allocations. Its top holdings as of the latest data include Insmed Inc (NASDAQ:INSM), Comfort Systems USA Inc (NYSE:FIX), and SoFi Technologies Inc (NASDAQ:SOFI), each representing a little over 1% of the fund. The fund has a long track record of 22 years, and its sector allocation shows a pronounced tilt toward technology relative to its peer.

SLYG, in contrast, covers 336 stocks and places slightly less weight on technology (19%), with industrials (18%), and healthcare (16%) close behind. Its largest positions include Arrowhead Pharmaceuticals In (NASDAQ:ARWR), Armstrong World Industries (NYSE:AWI), and Jbt Marel Corp (NYSE:JBTM).

Both funds avoid leverage, currency hedges, or ESG overlays, so investors should expect straightforward exposure to small-cap growth factors. SLYG’s selection process emphasizes sales growth and momentum, while VBK’s approach results in broader diversification and a heavier tech exposure.



Source link